Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer

被引：0
|
作者：
Brian M Nolen
Jeffrey R Marks
Shlomo Ta'san
Alex Rand
The Minh Luong
Yun Wang
Kimberly Blackwell
Anna E Lokshin
机构：
[1] University of Pittsburgh Cancer Institute,Department of Surgery
[2] Hillman Cancer Center,Department of Mathematical Sciences
[3] Duke University Medical Center,Department of Biostatistics, Graduate School of Public Health
[4] Carnegie Mellon University,Department of Radiation Oncology
[5] University of Pittsburgh,Department of Medicine
[6] Duke University Medical Center,Department of Medicine, School of Medicine
[7] Duke University Medical Center,Department of Pathology
[8] University of Pittsburgh,Department of Obstetrics and Gynecology RS
[9] University of Pittsburgh,undefined
[10] University of Pittsburgh,undefined
来源：
Breast Cancer Research | / 10卷
关键词：
Epidermal Growth Factor Receptor; Migration Inhibitory Factor; Median Fluorescence Intensity; Locally Advanced Breast Cancer; Clinical Partial Response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Serum levels of tumor necrosis factor alpha correlate with response to neoadjuvant chemotherapy in locally advanced breast cancer
    Berberoglu, U
    Yildirim, E
    Celen, O
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2004, 19 (02): : 130 - 134
  • [22] THE USEFULNESS OF SERUM VEGF LEVEL IN PREDICTING RESPONSE TO NEOADJUVANT CHEMOTHERAPY (NCT) IN PATIENTS WITH LOCALLY ADVANCED BREAST CANCER
    Wu, M.
    Midolo, P.
    Schneider-Kolsky, M.
    Hart, S.
    Susil, B.
    Stuckey, J.
    Fox, J.
    White, M.
    Andrew, S.
    Ganju, V.
    ANNALS OF ONCOLOGY, 2009, 20 : 46 - 46
  • [23] The influence of breast cancer subtypes on response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients
    Susnjar, S.
    Stamatovic, L.
    Gavrilovic, D.
    Minic, I.
    Ursulovic, T.
    BREAST, 2017, 32 : S81 - S82
  • [24] The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients
    Stamatovic, Ljiljana
    Susnjar, Snezana
    Gavrilovic, Dusica
    Minic, Ivana
    Ursulovic, Tamara
    Dzodic, Radan
    JOURNAL OF BUON, 2018, 23 (05): : 1273 - 1280
  • [25] Clinicopathologic Features and Biomarker Profiles of Breast Cancer In Association With Pathologic Response to Neoadjuvant Chemotherapy
    Boone, Jamie
    O'Neil, Maura
    Tawfik, Ossama
    Madan, Rashna
    Fan, Fang
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 138 : A278 - A278
  • [26] Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancer
    Fernández-Sánchez, M
    Gamboa-Dominguez, A
    Uribe, N
    García-Ulloa, AC
    Flores-Estrada, D
    Candelaria, M
    Arrieta, O
    MEDICAL ONCOLOGY, 2006, 23 (02) : 171 - 183
  • [27] The Validity of MRI in Evaluation of Tumor Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
    Abedi, Mahboobeh
    Farrokh, Donya
    Shandiz, Fatemeh Homaei
    Joulaee, Azadeh
    Anbiaee, Robab
    Zandi, Behrooz
    Gity, Masoumeh
    Sayah, Hamid Reza
    Abedi, Mohammad Sadegh
    IRANIAN JOURNAL OF CANCER PREVENTION, 2013, 6 (01) : 28 - 35
  • [28] Correlation between response to neoadjuvant chemotherapy and survival in locally advanced breast cancer patients
    Romero, A.
    Garcia-Saenz, J. A.
    Fuentes-Ferrer, M.
    Lopez Garcia-Asenjo, J. A.
    Furio, V.
    Roman, J. M.
    Moreno, A.
    de la Hoya, M.
    Diaz-Rubio, E.
    Martin, M.
    Caldes, T.
    ANNALS OF ONCOLOGY, 2013, 24 (03) : 655 - 661
  • [29] miRNA profile predicts response to neoadjuvant chemotherapy in locally advanced breast cancer patients
    Sichieri, R. D.
    Silveira, W. A.
    Tirapelli, D. P. C.
    Oliveira, T. M. G.
    Mandarano, L. R. M.
    Muglia, V.
    Andrade, J. M.
    Tiezzi, D.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S199 - S199
  • [30] Stromal Cell Signature Associated with Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
    Hirata Katayama, Maria Lucia
    Costa Vieira, Rene Aloisio
    Andrade, Victor Piana
    Roela, Rosimeire Aparecida
    Cernaglia Aureliano Lima, Luiz Guilherme
    Kerr, Ligia Maria
    de Campos, Adriano Polpo
    de Braganca Pereira, Carlos Alberto
    de Menezes Pacheco Serio, Pedro Adolpho
    Encinas, Giselly
    Maistro, Simone
    Leite Petroni, Matheus de Almeida
    Brentani, Maria Mitzi
    Azevedo Koike Folgueira, Maria Aparecida
    CELLS, 2019, 8 (12)
12345